ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 63 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $20,000 | -66.7% | 34,151 | -59.5% | 0.00% | – |
Q1 2022 | $60,000 | -74.9% | 84,280 | -53.5% | 0.00% | – |
Q4 2021 | $239,000 | -32.3% | 181,396 | +18.1% | 0.00% | -100.0% |
Q3 2021 | $353,000 | -58.9% | 153,544 | -21.5% | 0.00% | -50.0% |
Q2 2021 | $858,000 | +3.7% | 195,545 | +71.7% | 0.00% | 0.0% |
Q1 2021 | $827,000 | +347.0% | 113,885 | +165.8% | 0.00% | – |
Q4 2020 | $185,000 | +25.9% | 42,851 | +19.9% | 0.00% | – |
Q3 2020 | $147,000 | -36.1% | 35,746 | -6.6% | 0.00% | -100.0% |
Q2 2020 | $230,000 | -23.1% | 38,262 | -3.7% | 0.00% | 0.0% |
Q1 2020 | $299,000 | – | 39,714 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |